Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives

Minimal residual disease (MRD) detection represents a sensitive tool to appropriately measure the response obtained with therapies for multiple myeloma (MM). The achievement of MRD negativity has superseded the conventional complete response (CR) and has been proposed as a surrogate endpoint for pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mina, Roberto, Oliva, Stefania, Boccadoro, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408660/
https://www.ncbi.nlm.nih.gov/pubmed/32645952
http://dx.doi.org/10.3390/jcm9072142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408660/
https://www.ncbi.nlm.nih.gov/pubmed/32645952
http://dx.doi.org/10.3390/jcm9072142

Ejemplares similares